Results for tag: "Bremelanotide"

Bremelanotide is a peptide drug used to treat sexual dysfunction in both men and women. It is a melanocortin receptor agonist, meaning it stimulates the body's natural production of hormones that are involved in sexual arousal. It is administered as a subcutaneous injection and is the only drug of its kind approved by the US Food and Drug Administration (FDA) for the treatment of hypoactive sexual desire disorder (HSDD) in premenopausal women. Bremelanotide has been shown to improve sexual desire, arousal, and satisfaction in clinical trials. It is also being studied for its potential to treat other sexual and reproductive health conditions, such as erectile dysfunction, premature ejaculation, and female sexual arousal disorder. The Bremelanotide market is growing rapidly as more people become aware of the drug's potential to treat sexual dysfunction. It is expected to continue to expand as more clinical trials are conducted and more countries approve its use. Companies in the Bremelanotide market include Palatin Technologies, Inc., AMAG Pharmaceuticals, Inc., and Trimel Pharmaceuticals Corporation. Show Less Read more